In October 2026, the Hainan Free‑Trade Port Intellectual Property Court concluded and released a ruling on a dispute involving trademark infringement and unfair competition concerning the "YangShengTang" mark. The judgment sets out clear criteria for dividing liabilities between producers and sellers.
A pharmaceutical company was ordered to pay RMB 1.236 million for prominently using marks containing “YangShengTang” on product packaging. Haikou Trading Firm, which sold the same infringing goods, successfully invoked the legal‑source defence for the trademark‑infringement claim by submitting complete purchase documents. It was only ordered to pay RMB 2,000 for unfair competition arising from its online‑shop name.
The plaintiffs are YangShengTang Company and its licensed user, YangShengTang Pharmaceutical Company. YangShengTang Company is the proprietor of the registered trademark “YangShengTang”. There are two defendants: a pharmaceutical company, producer of the infringing goods; and a Haikou‑based trading firm, the seller of the infringing goods.
The cause of action covers trademark infringement and unfair competition. The two plaintiffs requested the court to order both defendants to cease infringement, publish an apology statement, and jointly compensate RMB 5 million for economic losses plus RMB 36,000 in reasonable enforcement expenses.
The registered trademark “YangShengTang” was recognised as a well‑known trademark in 1999 and enjoys high reputation in the pharmaceutical and health‑product sector. YangShengTang Company owns the trademark and has licensed its use to YangShengTang Pharmaceutical Company.
As found by the court, the pharmaceutical company prominently displayed marks containing “YangShengTang” on the outer packaging of multiple manufactured and sold products. Such marks include “YangShengTang Chinese Medicine Science Research Institute” and “YangShengTang Chinese Medicine Science Research Institute · Technical Support”. It also sold these goods through an online store on the Alibaba platform.
The defendant Haikou trading firm operated a Douyin store under the name “XX YangShengTang”, selling goods manufactured by the aforesaid pharmaceutical company whose packaging bore the words “Hong Kong YangShengTang”.
During the hearing, both defendants presented their defences regarding conduct and liability. In particular, the Haikou trading firm submitted purchase orders, logistics records and supplier information from its upstream supplier to support its legal‑source‑defence argument.
The court made the following findings of fact:
Taking into account the reputation of the trademark, circumstances of infringement and degree of fault of each defendant, the court rendered its judgment and drew clear distinctions between liabilities for producers and sellers.
First, cessation of infringement and elimination of adverse effects:
Both defendants shall immediately cease the alleged trademark‑infringement and unfair‑competition acts. The pharmaceutical company shall publish a statement to eliminate adverse consequences caused by its infringing conduct.
Second, liabilities of the producer:
The pharmaceutical company committed trademark infringement by prominently using marks containing “YangShengTang” on product outer packaging. The court ordered it to pay the two plaintiffs a total of RMB 1,236,000, covering economic losses and reasonable litigation‑related expenses.
Third, liabilities of the seller:
The Haikou trading firm’s sale of infringing goods itself constitutes trademark infringement. Nevertheless, it submitted complete purchase orders, logistics records and supplier information proving lawful acquisition of the disputed goods. The court upheld its legal‑source defence and exempted it from compensation liability for this part of the claim.
However, the trading firm’s use of “YangShengTang” in its Douyin shop name constitutes an independent act of unfair competition, which cannot be exempted merely by lawful sourcing of goods. The court finally ordered it to pay RMB 2,000 as compensation for economic losses to the two plaintiffs.
This case is designated by the Hainan Free‑Trade Port Intellectual Property Court as a typical intellectual‑property dispute featuring co‑existing trademark‑infringement and unfair‑competition conducts, as well as clear liability differentiation between producers and sellers.
A key distinction emerges from this judgment: the legal‑source‑defence rule applies only to the act of selling infringing goods, and does not extend to independent unfair‑competition conduct. The judicial logic delivers two layers of messages:
地址:广州市天河区体育东路116号财富广场东塔18楼
电话:020-22263200,020-22263284
传真:020-22263218
E-mail:smr@smr.com.cn

赛立信研究集团 2017 版权所有 Copyright © 2016 smr.com.cn All Rights Reserved. 粤ICP备:11102332号